id|source|source_url|synonyms|term_name
EFO_0022197|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||blood 3-hydroxymyristate measurement
EFO_0007221|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""Pleuropneumonia, Contagious"", ""contagious pleuropneumonia""]"|contagious pleuropneumonia
EFO_0803495|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""33-dibromobisphenol A""]"|dibromobisphenol a measurement
EFO_1001077|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""Idiopathic orbital inflammation"", ""Inflammatory pseudotumor of orbit (disorder)"", ""Orbital Pseudotumor"", ""Pseudotumor of orbit""]"|orbital plasma cell granuloma
EFO_0001196|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""IMR90""]"|IMR-90
EFO_0801158|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""dimethylguanidino valeric acid""]"|DMGV measurement
EFO_0803246|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||v-set and transmembrane domain-containing protein 2-like protein measurement
EFO_0007771|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||pathologic complete response measurement
EFO_0022833|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""RCB1638""]"|Hepa 1-6
EFO_0009226|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""HGBMHGB"", ""Methemoglobin/Total Hemoglobin""]"|Methemoglobin to Total Hemoglobin Ratio Measurement
EFO_0002671|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||iberin
EFO_0007965|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||response to combination chemotherapy
EFO_0020396|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||g2/mitotic-specific cyclin-B1 measurement
EFO_0022604|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""10X 3 v4"", ""10X 3 v4 sequencing"", ""10x 3 v4 sequencing""]"|10x 3 v4
EFO_1001020|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""MCNS"", ""idiopathic minimal change nephrotic syndrome"", ""minimal change glomerulopathy"", ""minimal change nephrotic syndrome"", ""nephrotic syndrome with lesion of minimal change glomerulonephritis"", ""nephrotic syndrome with lesion of minimal change nephrotic syndrome"", ""Minimal Change Glomerulonephritis"", ""Minimal change disease (disorder)"", ""Nephrosis, Lipoid"", ""Nephrotic syndrome with Lesion of Minimal Change Glomerulonephritis"", ""Nephrotic syndrome with lesion of minimal change glomerulonephritis"", ""Nephrotic syndrome with lesion of minimal change nephrotic syndrome"", ""lipoid nephrosis"", ""minimal change disease"", ""minimal change glomerulonephritis"", ""minimal change nephropathy"", ""nil disease""]"|lipoid nephrosis
EFO_0003898|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""Ankylosing Spondylarthritides"", ""Ankylosing Spondylarthritis"", ""Ankylosing Spondyloarthritides"", ""Ankylosing Spondyloarthritis"", ""BECHTEREW DIS"", ""BECHTEREWS DIS"", ""Bechterew Disease"", ""Bechterews Disease"", ""Bechterews Disease"", ""Bekhterev syndrome"", ""Bekhterevs disease"", ""MARIE STRUEMPELL DIS"", ""Marie Struempell Disease"", ""Marie-Struempell Disease"", ""Marie-Strumpell disease"", ""Rheumatoid Spondylitis"", ""Spondylarthritides, Ankylosing"", ""Spondylarthritis Ankylopoietica"", ""Spondylarthritis, Ankylosing"", ""Spondylitis, Ankylosing"", ""Spondylitis, Rheumatoid"", ""Spondyloarthritides, Ankylosing"", ""Spondyloarthritis, Ankylosing"", ""ankylosing spondylarthritis"", ""ankylosing spondylitis""]"|ankylosing spondylitis
EFO_0801180|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||metronidazole measurement
EFO_0600042|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""serum clozapine-to-norclozapine ratio measurement""]"|serum clozapine-to-N-desmethylclozapine ratio measurement
EFO_0800639|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||N6-methyladenosine measurement
EFO_0002055|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||G1E-ER4
EFO_0005444|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""OVCAR-8"", ""OVCAR.8""]"|OVCAR8
EFO_0802976|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||protrudin measurement
EFO_0803563|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||C38:3 phosphatidylserine plasmalogen measurement
EFO_1001982|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""AS syndrome"", ""Anti-Jo1 syndrome"", ""Anti-Synthetase Syndrome"", ""anti-Jo1 syndrome"", ""antisynthetase syndrome""]"|Antisynthetase syndrome
EFO_0009690|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""disease of renal system"", ""disease or disorder of renal system"", ""disease, urinary tract"", ""disease, urologic"", ""disease, urological"", ""diseases, urinary tract"", ""diseases, urologic"", ""diseases, urological"", ""disorder of renal system"", ""disorder of the urinary system"", ""disorder of urinary system"", ""non-neoplastic urinary tract disease"", ""renal system disease"", ""renal system disease or disorder"", ""urinary disease"", ""urinary system disease"", ""urinary system disorder"", ""urinary tract disease"", ""urinary tract diseases"", ""urinary tract disorder"", ""urologic disease"", ""urologic disorder"", ""urological disease"", ""urological diseases"", ""urological disorder"", ""urological disorders""]"|urinary system disease
EFO_0010480|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||fumarate measurement
EFO_0007148|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""Corrigans disease"", ""Aortic Valve Insufficiency"", ""Rheumatic aortic insufficiency"", ""Rheumatic aortic regurgitation"", ""Rheumatic aortic valve regurgitation"", ""aortic incompetence"", ""aortic insufficiency"", ""aortic regurgitation"", ""aortic valve insufficiency"", ""rheumatic aortic insufficiency"", ""rheumatic aortic regurgitation"", ""rheumatic aortic valve insufficiency"", ""rheumatic aortic valve regurgitation""]"|aortic valve insufficiency
EFO_0010063|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||Therapeutic Procedure
EFO_0002764|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||ChIP-chip by SNP array
EFO_0800592|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||picolinoylglycine measurement
EFO_0022363|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||SLB-1 cells
EFO_0001431|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||twin design
EFO_0800678|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||leucylglycine measurement
EFO_0009158|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""PEBEL"", ""encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy"", ""encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy  PEBEL"", ""encephalopathy, progressive, early-onset, with brain oedema and/or leukoencephalopathy  PEBEL""]"|encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy
EFO_0020105|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||trunk bone mineral density
EFO_0802209|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||vacuolar protein sorting-associated protein 4B measurement
EFO_0002068|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||Kc
EFO_0800117|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||N-acetylvaline measurement
EFO_0004337|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""cognitive ability"", ""general cognitive ability"", ""general cognitive function""]"|intelligence
EFO_0008643|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||3â€²-Seq
EFO_0005377|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""UACC.62""]"|UACC-62
EFO_0801447|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||carbohydrate sulfotransferase 1 measurement
EFO_0021940|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||latent-transforming growth factor beta-binding protein 4 measurement
EFO_0004799|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""gallstones"", ""cholelithiasis""]"|cholelithiasis
EFO_0005410|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""familial tooth agenesis"", ""hypodontia"", ""selective tooth agenesis"", ""tooth agenesis"", ""tooth agenesis, selective""]"|tooth agenesis
EFO_0006397|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||G118
EFO_0802460|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||deoxyribonuclease-2-beta measurement
EFO_0802875|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||poliovirus receptor measurement
EFO_0000450|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||embryonic cuprophilic cell
EFO_0801445|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||calpain-2 catalytic subunit measurement
EFO_0009602|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""disease of prostate gland"", ""disease or disorder of prostate gland"", ""disorder of prostate gland"", ""prostate disease"", ""prostate disorder"", ""prostate gland disease"", ""prostate gland disease or disorder""]"|prostate disease
EFO_0010990|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||dimethylamine measurement
EFO_0002869|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""U2-OS""]"|U2OS
EFO_0802108|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||synaptotagmin-11 measurement
EFO_0022387|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""SJL/J-Pde6b^rd1"", ""Swiss Jim Lambert""]"|SJL/J
EFO_0004442|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||AB SOLiD System 2.0
EFO_0800871|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||X-24307 measurement
EFO_1000050|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""kidney leiomyoma"", ""leiomyoma of kidney"", ""renal leiomyoma""]"|renal leiomyoma
EFO_0021901|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||cholesterol in large LDL measurement 
EFO_0802322|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||beta-defensin 116 measurement
EFO_0021080|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||1-eicosadienoylglycerophosphocholine measurement
EFO_0008822|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||MPRA
EFO_1001783|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""Fibroma, Desmoplastic""]"|desmoplastic fibroma
EFO_0803197|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||tubulointerstitial nephritis antigen-like measurement
EFO_0801514|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||cytochrome c oxidase subunit 4 isoform 2, mitochondrial measurement
EFO_0021510|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||linoleate 18:2n6 measurement
EFO_0009131|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||response to polyunsaturated fatty acid supplementation
EFO_0010954|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""XL-ID"", ""x-linked cask-related intellectual disability""]"|cask-related x-linked intellectual disability
EFO_1001165|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""chronic urticaria with gammapathy"", ""Schnitzler Syndrome"", ""Schnitzler syndrome"", ""Schnitzler syndrome (disorder)"", ""chronic urticaria with gammopathy"", ""chronic urticaria with macroglobulinemia""]"|Schnitzler syndrome
EFO_0007316|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""HTLV-1"", ""Human T lymphotropic virus type 1"", ""HTLV-1 infectious disease"", ""HTLV-I Infections"", ""HTLV-I infectious disease"", ""Human T-lymphotropic virus 1 caused disease or disorder"", ""Human T-lymphotropic virus 1 disease or disorder"", ""Human T-lymphotropic virus 1 infectious disease"", ""human T-lymphotropic virus 1 infectious disease""]"|Human T-lymphotropic virus 1 infectious disease
EFO_0800066|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||6-oxopiperidine-2-carboxylate measurement
EFO_0008983|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||VirScan
EFO_0002359|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||SW1116
EFO_0022346|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||76N cell
EFO_0006805|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||word list delayed recall measurement
EFO_0800366|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||1-oleoyl-GPG (18:1) measurement
EFO_0001115|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||GM07345
EFO_0007534|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""Venezuelan equine fever"", ""Encephalomyelitis, Venezuelan Equine"", ""Venezuelan equine encephalitis"", ""Venezuelan equine encephalitis virus caused disease or disorder"", ""Venezuelan equine encephalitis virus disease or disorder"", ""Venezuelan equine encephalitis virus infectious disease""]"|Venezuelan equine encephalitis
EFO_0002052|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||EcR-RKO/KLF4
EFO_0021678|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||beta-Pseudouridine measurement
EFO_0801171|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||indole-3-lactic acid measurement
EFO_0803097|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||speckle-type POZ protein measurement
EFO_0021331|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||X-12749 measurement
EFO_0004062|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||NL2099
EFO_0021270|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||X-11850 measurement
EFO_0007187|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""Old Age pemphigus"", ""Parapemphigus"", ""benign pemphigus"", ""senile dermatitis herpetiformis"", ""Bullous pemphigoid"", ""Bullous pemphigoid (disorder)"", ""Pemphigoid, Bullous"", ""bullous pemphigoid""]"|bullous pemphigoid
EFO_0008422|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||susceptibility to infectious disease measurement
EFO_1001403|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""post partum thyroiditis"", ""post-partum thyroiditides"", ""post-partum thyroiditis"", ""postpartum thyroiditides"", ""thyroiditides, post-partum"", ""thyroiditides, postpartum"", ""thyroiditis, post-partum"", ""thyroiditis, postpartum"", ""postpartum thyroiditis""]"|postpartum thyroiditis
EFO_0800433|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||myristoyl dihydrosphingomyelin (d18:0/14:0) measurement
EFO_0000393|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""RB""]"|Robertsonian translocation
EFO_0801819|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||n-acetyltransferase 14 measurement
EFO_1000608|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""Xanthosarcoma"", ""inflammatory MFH"", ""inflammatory malignant fibrous histiocytoma"", ""malignant xanthogranuloma"", ""undifferentiated pleomorphic sarcoma, inflammatory variant""]"|Undifferentiated Pleomorphic Sarcoma, Inflammatory Variant
EFO_0010540|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||thiamine measurement
EFO_0802492|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||DnaJ homolog subfamily C member 4 measurement
EFO_0010507|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||lactose measurement
EFO_0005495|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""neurosecretory-motor neuron""]"|NSM
EFO_0001771|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""normalization_testing_design""]"|normalization testing design
EFO_0020844|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||ubiquitin+1, truncated mutation for UBB measurement
EFO_0001087|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||AU565
EFO_0000352|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl|"[""ClinicalHistory"", ""clinical information""]"|clinical history
EFO_0008434|Experimental Factor Ontology|http://www.ebi.ac.uk/efo/efo.owl||initial pursuit acceleration
